209 related articles for article (PubMed ID: 37149292)
1. Cost-effectiveness of point-of-care versus centralised, laboratory-based nucleic acid testing for diagnosis of HIV in infants: a systematic review of modelling studies.
le Roux SM; Odayar J; Sutcliffe CG; Salvatore PP; de Broucker G; Dowdy D; McCann NC; Frank SC; Ciaranello AL; Myer L; Vojnov L
Lancet HIV; 2023 May; 10(5):e320-e331. PubMed ID: 37149292
[TBL] [Abstract][Full Text] [Related]
2. Clinical effect and cost-effectiveness of incorporation of point-of-care assays into early infant HIV diagnosis programmes in Zimbabwe: a modelling study.
Frank SC; Cohn J; Dunning L; Sacks E; Walensky RP; Mukherjee S; Dugdale CM; Turunga E; Freedberg KA; Ciaranello AL
Lancet HIV; 2019 Mar; 6(3):e182-e190. PubMed ID: 30737187
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a routine point-of-care intervention for early infant diagnosis of HIV: an observational study in eight African countries.
Bianchi F; Cohn J; Sacks E; Bailey R; Lemaire JF; Machekano R;
Lancet HIV; 2019 Jun; 6(6):e373-e381. PubMed ID: 30987937
[TBL] [Abstract][Full Text] [Related]
4. The cost-effectiveness of scaling-up rapid point-of-care testing for early infant diagnosis of HIV in southern Zambia.
De Broucker G; Salvatore PP; Mutembo S; Moyo N; Mutanga JN; Thuma PE; Moss WJ; Sutcliffe CG
PLoS One; 2021; 16(3):e0248217. PubMed ID: 33690733
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Modeling the cost-effectiveness of point-of-care platforms for infant diagnosis of HIV in sub-Saharan African countries.
Salvatore PP; de Broucker G; Vojnov L; Moss WJ; Dowdy DW; Sutcliffe CG
AIDS; 2021 Feb; 35(2):287-297. PubMed ID: 33394672
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of point-of-care testing with task-shifting for HIV care in South Africa: a modelling study.
Sharma M; Mudimu E; Simeon K; Bershteyn A; Dorward J; Violette LR; Akullian A; Abdool Karim SS; Celum C; Garrett N; Drain PK
Lancet HIV; 2021 Apr; 8(4):e216-e224. PubMed ID: 33347810
[TBL] [Abstract][Full Text] [Related]
8. Strengthening Existing Laboratory-Based Systems vs. Investing in Point-of-Care Assays for Early Infant Diagnosis of HIV: A Model-Based Cost-Effectiveness Analysis.
McCann NC; Cohn J; Flanagan C; Sacks E; Mukherjee S; Walensky RP; Adetunji O; Maeka KK; Panella C; Chadambuka A; Mafaune H; Odhiambo C; Freedberg KA; Ciaranello AL
J Acquir Immune Defic Syndr; 2020 Jul; 84 Suppl 1(1):S12-S21. PubMed ID: 32520910
[TBL] [Abstract][Full Text] [Related]
9. Optimizing infant HIV diagnosis with additional screening at immunization clinics in three sub-Saharan African settings: a cost-effectiveness analysis.
Dunning L; Gandhi AR; Penazzato M; Soeteman DI; Revill P; Frank S; Phillips A; Dugdale C; Abrams E; Weinstein MC; Newell ML; Collins IJ; Doherty M; Vojnov L; Fassinou Ekouévi P; Myer L; Mushavi A; Freedberg KA; Ciaranello AL
J Int AIDS Soc; 2021 Jan; 24(1):e25651. PubMed ID: 33474817
[TBL] [Abstract][Full Text] [Related]
10. Impact of hepatitis C virus point-of-care RNA viral load testing compared with laboratory-based testing on uptake of RNA testing and treatment, and turnaround times: a systematic review and meta-analysis.
Trickey A; Fajardo E; Alemu D; Artenie AA; Easterbrook P
Lancet Gastroenterol Hepatol; 2023 Mar; 8(3):253-270. PubMed ID: 36706775
[TBL] [Abstract][Full Text] [Related]
11. The clinical and economic impact of point-of-care CD4 testing in mozambique and other resource-limited settings: a cost-effectiveness analysis.
Hyle EP; Jani IV; Lehe J; Su AE; Wood R; Quevedo J; Losina E; Bassett IV; Pei PP; Paltiel AD; Resch S; Freedberg KA; Peter T; Walensky RP
PLoS Med; 2014 Sep; 11(9):e1001725. PubMed ID: 25225800
[TBL] [Abstract][Full Text] [Related]
12. Point-of-care tests detecting HIV nucleic acids for diagnosis of HIV-1 or HIV-2 infection in infants and children aged 18 months or less.
Ochodo EA; Guleid F; Deeks JJ; Mallett S
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD013207. PubMed ID: 34383961
[TBL] [Abstract][Full Text] [Related]
13. The clinical effect of point-of-care HIV diagnosis in infants: a systematic review and meta-analysis.
Luo R; Fong Y; Boeras D; Jani I; Vojnov L
Lancet; 2022 Sep; 400(10356):887-895. PubMed ID: 36116479
[TBL] [Abstract][Full Text] [Related]
14. Point-of-care HIV testing best practice for early infant diagnosis: an implementation study.
Spooner E; Govender K; Reddy T; Ramjee G; Mbadi N; Singh S; Coutsoudis A
BMC Public Health; 2019 Jun; 19(1):731. PubMed ID: 31185962
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of point-of-care viral load monitoring of antiretroviral therapy in resource-limited settings: mathematical modelling study.
Estill J; Egger M; Blaser N; Vizcaya LS; Garone D; Wood R; Campbell J; Hallett TB; Keiser O;
AIDS; 2013 Jun; 27(9):1483-92. PubMed ID: 23462219
[TBL] [Abstract][Full Text] [Related]
16. Point-of-care testing can achieve same-day diagnosis for infants and rapid ART initiation: results from government programmes across six African countries.
Boeke CE; Joseph J; Wang M; Abate ZM; Atem C; Coulibaly KD; Kebede A; Kiernan B; Kingwara L; Mangwendeza P; Maparo T; Mbaye RN; Mukungunugwa S; Ngugi C; Nzuobontane D; Okomo Assoumou MC; Reta Y; Wambugu B; Rioja MR; Peter T; Doi N; Vojnov L; Khan S; Sacks JA
J Int AIDS Soc; 2021 Mar; 24(3):e25677. PubMed ID: 33745234
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of integrating postpartum antiretroviral therapy and infant care into maternal & child health services in South Africa.
Dugdale CM; Phillips TK; Myer L; Hyle EP; Brittain K; Freedberg KA; Cunnama L; Walensky RP; Zerbe A; Weinstein MC; Abrams EJ; Ciaranello AL;
PLoS One; 2019; 14(11):e0225104. PubMed ID: 31730630
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of broadly neutralizing antibody prophylaxis for HIV-exposed infants in sub-Saharan African settings.
Dugdale CM; Ufio O; Alba C; Permar SR; Stranix-Chibanda L; Cunningham CK; Fouda GG; Myer L; Weinstein MC; Leroy V; McFarland EJ; Freedberg KA; Ciaranello AL
J Int AIDS Soc; 2023 Jan; 26(1):e26052. PubMed ID: 36604316
[TBL] [Abstract][Full Text] [Related]
19. A Randomized Trial of Point-of-Care Early Infant Human Immunodeficiency Virus (HIV) Diagnosis in Zambia.
Chibwesha CJ; Mollan KR; Ford CE; Shibemba A; Saha PT; Lusaka M; Mbewe F; Allmon AG; Lungu R; Spiegel HML; Mweni E; Mwape H; Kankasa C; Chi BH; Stringer JSA
Clin Infect Dis; 2022 Aug; 75(2):260-268. PubMed ID: 34718462
[TBL] [Abstract][Full Text] [Related]
20. Point-of-care viral load tests to detect high HIV viral load in people living with HIV/AIDS attending health facilities.
Ochodo EA; Olwanda EE; Deeks JJ; Mallett S
Cochrane Database Syst Rev; 2022 Mar; 3(3):CD013208. PubMed ID: 35266555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
